NASDAQ:OMTH

Omthera Pharmaceuticals (OMTH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OMTH stock logo

About Omthera Pharmaceuticals Stock (NASDAQ:OMTH)

Omthera Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular disease. Epanova, its product candidate, is a late-stage, omega-three free fatty acid composition that reduces triglycerides, improves other key lipid parameters. Epanova is a coated soft gelatin capsule containing a complex mixture of polyunsaturated free fatty acids derived from fish oils, including multiple long-chain omega-three and omega-six fatty acids, with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and docosapentaenoic acid being the most abundant forms of omega-three fatty acids. The Company has completed pharmacokinetic and Phase III clinical studies to investigate the safety and efficacy profile of Epanova.

OMTH Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
See More Headlines
Receive OMTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omthera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:OMTH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

OMTH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Omthera Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omthera Pharmaceuticals investors own include Scorpio Tankers (STNG), Avon Products (AVP), Corcept Therapeutics (CORT), Ceragon Networks (CRNT), Direxion Daily CSI China Internet Index Bull 2x Shares (CWEB), Cypress Semiconductor (CY), Denali Therapeutics (DNLI) and Invitae (NVTA).

This page (NASDAQ:OMTH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners